CVS Health Corp (NYSE:CVS) has been assigned an average rating of “Buy” from the twenty-seven ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, seven have given a hold recommendation, fifteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $75.55.

CVS has been the subject of several recent research reports. Morgan Stanley boosted their price target on Thomson Reuters from $66.00 to $67.00 and gave the company an “overweight” rating in a research note on Monday, April 29th. CIBC reiterated a “market perform” rating on shares of CVS Health in a research note on Monday, April 15th. BMO Capital Markets set a $66.00 price target on CyrusOne and gave the company a “buy” rating in a research note on Friday, May 3rd. Guggenheim reiterated a “sell” rating on shares of Rite Aid in a research note on Thursday, April 18th. Finally, Oppenheimer upped their target price on Check Point Software Technologies from $130.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, April 15th.

Shares of CVS stock traded down $0.34 during trading on Tuesday, hitting $55.92. The company had a trading volume of 84,552 shares, compared to its average volume of 6,856,759. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.45. The company has a market cap of $72.58 billion, a price-to-earnings ratio of 7.90, a P/E/G ratio of 1.25 and a beta of 0.88. The stock’s 50-day simple moving average is $55.23. CVS Health has a one year low of $51.72 and a one year high of $82.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.50 by $0.12. The business had revenue of $61.65 billion during the quarter, compared to analysts’ expectations of $60.39 billion. CVS Health had a positive return on equity of 16.80% and a negative net margin of 0.08%. The firm’s revenue for the quarter was up 34.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.48 earnings per share. On average, analysts predict that CVS Health will post 6.84 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 2nd. Stockholders of record on Thursday, July 25th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.58%. The ex-dividend date is Wednesday, July 24th. CVS Health’s payout ratio is 28.25%.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Northern Oak Wealth Management Inc. increased its holdings in CVS Health by 3.4% in the second quarter. Northern Oak Wealth Management Inc. now owns 113,820 shares of the pharmacy operator’s stock valued at $6,202,000 after purchasing an additional 3,698 shares during the period. Kanawha Capital Management LLC increased its holdings in CVS Health by 15.0% in the second quarter. Kanawha Capital Management LLC now owns 58,989 shares of the pharmacy operator’s stock valued at $3,214,000 after purchasing an additional 7,714 shares during the period. Private Ocean LLC increased its holdings in CVS Health by 1,708.2% in the second quarter. Private Ocean LLC now owns 886 shares of the pharmacy operator’s stock valued at $48,000 after purchasing an additional 837 shares during the period. Point View Wealth Management Inc. increased its holdings in CVS Health by 48.9% in the second quarter. Point View Wealth Management Inc. now owns 42,860 shares of the pharmacy operator’s stock valued at $2,335,000 after purchasing an additional 14,085 shares during the period. Finally, Janney Montgomery Scott LLC increased its holdings in CVS Health by 16.9% in the second quarter. Janney Montgomery Scott LLC now owns 836,532 shares of the pharmacy operator’s stock valued at $45,583,000 after purchasing an additional 121,174 shares during the period. Institutional investors own 77.28% of the company’s stock.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Recommended Story: What does cost of debt say about a company’s financial health?

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.